Genelux (GNLX) Amortizatization of Intangibles (2022 - 2026)

Genelux (GNLX) recorded quarterly Amortizatization of Intangibles of $89000.0 in Q1 2026, up 187.1% quarter-over-quarter from $31000.0 in Q3 2025, and down 36.43% on a YoY basis from $140000.0 in Q1 2025.

Genelux (GNLX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Genelux's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $89000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 36.43% year-over-year to $89000.0; the TTM figure through Mar 2026 stood at $277000.0 (down 60.2% YoY), while the FY2023 annual figure was $62000.0, down 75.97% from the prior year.
  • Amortizatization of Intangibles was $89000.0 for Q1 2026 at Genelux, up from $31000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $649000.0 in Q1 2023 to a low of -$587000.0 in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $91916.7 across 5 years, with a median of $99500.0 in 2022.
  • Biggest YoY gain for Amortizatization of Intangibles was 1224.49% in 2023; the steepest drop was 633.64% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $110000.0 in 2022, then tumbled by 633.64% to -$587000.0 in 2023, then surged by 142.93% to $252000.0 in 2024, then plunged by 87.7% to $31000.0 in 2025, then surged by 187.1% to $89000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $89000.0 (Q1 2026), $31000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Genelux 129.36 Mn 129.36 Mn - 89,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 89,000.00
Mar 31, 2026 89,000.00
Sep 30, 2025 31,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 17,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 140,000.00
Mar 31, 2025 140,000.00
Sep 30, 2024 252,000.00
Sep 30, 2024 252,000.00
Jun 30, 2024 153,000.00
Jun 30, 2024 153,000.00
Mar 31, 2024 151,000.00
Mar 31, 2024 151,000.00
Dec 31, 2023 -587,000.00
Dec 31, 2023 -587,000.00
Mar 31, 2023 649,000.00
Mar 31, 2023 649,000.00
Dec 31, 2022 110,000.00
Dec 31, 2022 110,000.00